Table 6.
Basic data of patients in three groups before loss to follow-up
| Variables | Group S (n = 32) | Group R (n = 32) | Group RD (n = 32) | p-values |
|---|---|---|---|---|
| Gender, n (%) | 0.435 | |||
| Male | 24 (75.00) | 22 (66.75) | 26 (81.25) | |
| Female | 8 (25.00) | 10 (33.25) | 6 (18.75) | |
| Age (years) | 62.93 (7.98) | 60.43 (8.78) | 60.13 (8.02) | 0.359 |
| ASA status | 0.954 | |||
| I | 11 (34.38) | 10 (31.25) | 10 (31.25) | |
| II | 21 (65.62) | 22 (68.75) | 22 (68.75) | |
| BMI (kg/m2) | 21.11 (3.11) | 21.84 (3.44) | 21.11 (2.58) | 0.433 |
| Heart rate | 75.24 (10.32) | 72.63 (9.60) | 76.27 (16.47) | 0.512 |
| Mean arterial pressure (mmHg) | 93.73 (14.92) | 95.90 (9.77) | 100.23 (14.71) | 0.164 |
| SBP (mmHg) | 136.83 (26.16) | 134.83 (17.39) | 144.77 (23.37) | 0.204 |
| DBP (mmHg) | 72.47 (11.43) | 76.53 (8.90) | 75.65 (11.12) | 0.139 |
Notes: S, saline; R, 0.5% ropivacaine; RD, 5 mg dexamethasone and 0.5% ropivacaine.
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index.